| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis | 37 | 2016 | 1234 | 2.000 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 22 | 2015 | 799 | 1.490 |
Why?
|
| Intestinal Mucosa | 37 | 2018 | 3031 | 0.940 |
Why?
|
| Hepatitis B, Chronic | 6 | 2023 | 410 | 0.870 |
Why?
|
| B-Lymphocyte Subsets | 8 | 2008 | 238 | 0.860 |
Why?
|
| Inflammatory Bowel Diseases | 17 | 2018 | 2423 | 0.650 |
Why?
|
| T-Lymphocytes | 64 | 2007 | 10175 | 0.610 |
Why?
|
| Elasticity Imaging Techniques | 6 | 2020 | 391 | 0.610 |
Why?
|
| B-Lymphocytes | 27 | 2007 | 4745 | 0.600 |
Why?
|
| Colon | 18 | 2015 | 1791 | 0.550 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 11 | 2007 | 346 | 0.530 |
Why?
|
| Fatty Liver | 5 | 2022 | 787 | 0.520 |
Why?
|
| Th2 Cells | 8 | 2008 | 1056 | 0.520 |
Why?
|
| Antibodies, Monoclonal | 70 | 2016 | 9172 | 0.510 |
Why?
|
| CD4-Positive T-Lymphocytes | 21 | 2016 | 4366 | 0.490 |
Why?
|
| Antigens, CD | 16 | 2015 | 3998 | 0.470 |
Why?
|
| Mice, Knockout | 51 | 2019 | 14389 | 0.450 |
Why?
|
| Autoimmune Lymphoproliferative Syndrome | 1 | 2013 | 13 | 0.450 |
Why?
|
| Interleukin-10 | 9 | 2016 | 1172 | 0.450 |
Why?
|
| Langerhans Cells | 16 | 1986 | 170 | 0.440 |
Why?
|
| Intestines | 11 | 2017 | 1909 | 0.410 |
Why?
|
| Mice | 123 | 2022 | 81368 | 0.400 |
Why?
|
| Hepatitis B virus | 5 | 2023 | 527 | 0.400 |
Why?
|
| Alkaline Phosphatase | 5 | 2018 | 860 | 0.390 |
Why?
|
| Hepatitis B | 9 | 2023 | 702 | 0.370 |
Why?
|
| Lymphocytes | 15 | 2007 | 2604 | 0.350 |
Why?
|
| Lymphocyte Activation | 29 | 2019 | 5463 | 0.350 |
Why?
|
| Antigens, Surface | 28 | 2000 | 1605 | 0.350 |
Why?
|
| Immunoenzyme Techniques | 47 | 1998 | 1703 | 0.350 |
Why?
|
| T-Lymphocyte Subsets | 15 | 2011 | 1798 | 0.340 |
Why?
|
| Histocompatibility Antigens Class II | 22 | 2005 | 1434 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 49 | 2018 | 22115 | 0.330 |
Why?
|
| Salmonella Infections | 3 | 2016 | 172 | 0.330 |
Why?
|
| Animals | 152 | 2022 | 168201 | 0.320 |
Why?
|
| Liver Cirrhosis | 8 | 2018 | 1926 | 0.320 |
Why?
|
| Interferon-gamma | 15 | 2016 | 3145 | 0.320 |
Why?
|
| Hepatitis B Core Antigens | 5 | 2023 | 90 | 0.310 |
Why?
|
| Adoptive Transfer | 12 | 2014 | 818 | 0.300 |
Why?
|
| Dendritic Cells | 12 | 2015 | 2722 | 0.300 |
Why?
|
| Germ-Free Life | 1 | 2008 | 186 | 0.290 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2007 | 21 | 0.290 |
Why?
|
| Disease Models, Animal | 32 | 2019 | 18221 | 0.280 |
Why?
|
| Cytokines | 19 | 2017 | 7373 | 0.280 |
Why?
|
| Enteritis | 2 | 2012 | 162 | 0.280 |
Why?
|
| Keratins | 10 | 1994 | 498 | 0.270 |
Why?
|
| Interleukin-4 | 7 | 2007 | 1146 | 0.270 |
Why?
|
| Homeodomain Proteins | 12 | 2016 | 2413 | 0.270 |
Why?
|
| Liver | 17 | 2023 | 7512 | 0.260 |
Why?
|
| Flow Cytometry | 22 | 2015 | 5863 | 0.260 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2013 | 581 | 0.260 |
Why?
|
| Hepatitis C, Chronic | 7 | 2009 | 1018 | 0.260 |
Why?
|
| Mice, Mutant Strains | 11 | 2018 | 1748 | 0.260 |
Why?
|
| Receptors, Interleukin-10 | 2 | 2016 | 50 | 0.250 |
Why?
|
| Thrombocytopenia | 1 | 2013 | 1182 | 0.250 |
Why?
|
| Lymphoid Tissue | 6 | 2004 | 445 | 0.240 |
Why?
|
| Granuloma | 1 | 2007 | 328 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 11 | 2019 | 4571 | 0.240 |
Why?
|
| Genes, T-Cell Receptor alpha | 2 | 2002 | 19 | 0.240 |
Why?
|
| Antiviral Agents | 8 | 2021 | 3039 | 0.230 |
Why?
|
| Salmonella typhimurium | 3 | 2016 | 347 | 0.230 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 8 | 2004 | 897 | 0.230 |
Why?
|
| Aneurysm, Infected | 2 | 2001 | 82 | 0.220 |
Why?
|
| Kupffer Cells | 4 | 1993 | 143 | 0.210 |
Why?
|
| Chronic Disease | 19 | 2014 | 9311 | 0.210 |
Why?
|
| Colitis, Ulcerative | 8 | 2014 | 1921 | 0.210 |
Why?
|
| Skin | 24 | 2002 | 4473 | 0.210 |
Why?
|
| Paneth Cells | 2 | 2014 | 98 | 0.210 |
Why?
|
| Intestine, Small | 9 | 2015 | 1207 | 0.210 |
Why?
|
| Lymphoma | 11 | 1996 | 1899 | 0.210 |
Why?
|
| Autoimmune Diseases | 7 | 2018 | 2238 | 0.210 |
Why?
|
| Antigens | 13 | 2012 | 1441 | 0.200 |
Why?
|
| Hepatitis B Surface Antigens | 7 | 2023 | 293 | 0.200 |
Why?
|
| Thymus Gland | 15 | 2007 | 1243 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell | 12 | 2002 | 2546 | 0.200 |
Why?
|
| Kidney Glomerulus | 10 | 1993 | 568 | 0.200 |
Why?
|
| Liver Diseases | 4 | 2018 | 1297 | 0.200 |
Why?
|
| Myeloid Cells | 1 | 2007 | 823 | 0.200 |
Why?
|
| T-Lymphocytes, Cytotoxic | 5 | 2015 | 1779 | 0.190 |
Why?
|
| Germinal Center | 3 | 2004 | 380 | 0.190 |
Why?
|
| Antigen-Antibody Complex | 10 | 1985 | 509 | 0.190 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 2 | 2000 | 67 | 0.190 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 2019 | 1088 | 0.190 |
Why?
|
| Th1 Cells | 9 | 2011 | 1027 | 0.190 |
Why?
|
| Lymph Nodes | 22 | 2011 | 3461 | 0.190 |
Why?
|
| Microscopy, Electron | 22 | 1999 | 2561 | 0.180 |
Why?
|
| Interleukin-1 | 6 | 2011 | 1248 | 0.180 |
Why?
|
| Proteins | 13 | 2012 | 6030 | 0.180 |
Why?
|
| Prostatic Diseases | 1 | 2001 | 57 | 0.180 |
Why?
|
| Immunity, Cellular | 11 | 2006 | 1550 | 0.180 |
Why?
|
| Epitopes | 9 | 1996 | 2501 | 0.180 |
Why?
|
| T-Lymphocytes, Regulatory | 11 | 2015 | 3077 | 0.180 |
Why?
|
| Immunity, Mucosal | 7 | 2008 | 483 | 0.180 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 5 | 2011 | 161 | 0.180 |
Why?
|
| Membrane Glycoproteins | 8 | 2008 | 3688 | 0.180 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 2 | 2015 | 108 | 0.170 |
Why?
|
| Myxoma | 2 | 1998 | 114 | 0.170 |
Why?
|
| Autoantibodies | 7 | 1999 | 2115 | 0.170 |
Why?
|
| Antigens, CD1 | 2 | 2002 | 439 | 0.170 |
Why?
|
| HLA Antigens | 9 | 1987 | 1329 | 0.170 |
Why?
|
| HIV Infections | 8 | 2022 | 17337 | 0.170 |
Why?
|
| Ribavirin | 4 | 2006 | 392 | 0.160 |
Why?
|
| Celiac Disease | 3 | 2009 | 819 | 0.160 |
Why?
|
| Proteobacteria | 1 | 2018 | 46 | 0.160 |
Why?
|
| Aspergillosis | 1 | 2001 | 242 | 0.160 |
Why?
|
| Macrophages | 12 | 2016 | 5758 | 0.160 |
Why?
|
| Kidney Diseases | 6 | 2001 | 2090 | 0.150 |
Why?
|
| Major Histocompatibility Complex | 7 | 1999 | 870 | 0.150 |
Why?
|
| Humans | 208 | 2023 | 760617 | 0.150 |
Why?
|
| Lymphocyte Subsets | 3 | 1999 | 310 | 0.150 |
Why?
|
| Hepatitis B e Antigens | 4 | 2022 | 133 | 0.150 |
Why?
|
| Adherens Junctions | 1 | 2018 | 89 | 0.150 |
Why?
|
| Dermatitis, Atopic | 6 | 2002 | 731 | 0.150 |
Why?
|
| Interferon-alpha | 5 | 2006 | 902 | 0.140 |
Why?
|
| Cell Differentiation | 20 | 2015 | 11514 | 0.140 |
Why?
|
| Immune Tolerance | 6 | 2014 | 2299 | 0.140 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2017 | 36 | 0.140 |
Why?
|
| Inflammation | 13 | 2022 | 10760 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 16 | 2017 | 6188 | 0.140 |
Why?
|
| Bacteria, Aerobic | 1 | 1996 | 24 | 0.140 |
Why?
|
| Hexosyltransferases | 1 | 2016 | 58 | 0.140 |
Why?
|
| Adipocytes, Brown | 1 | 2017 | 150 | 0.140 |
Why?
|
| Cecum | 2 | 1996 | 233 | 0.130 |
Why?
|
| Phosphoproteins | 2 | 2018 | 2446 | 0.130 |
Why?
|
| Salmonella enterica | 1 | 2016 | 76 | 0.130 |
Why?
|
| Dextran Sulfate | 4 | 2012 | 258 | 0.130 |
Why?
|
| Interleukin-17 | 5 | 2016 | 911 | 0.130 |
Why?
|
| Receptors, Cell Surface | 4 | 2015 | 2802 | 0.130 |
Why?
|
| Hepacivirus | 7 | 2009 | 1330 | 0.130 |
Why?
|
| Immunoglobulin M | 9 | 2008 | 1526 | 0.130 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 1997 | 289 | 0.130 |
Why?
|
| Appendix | 1 | 1996 | 109 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2019 | 548 | 0.120 |
Why?
|
| Polyethylene Glycols | 4 | 2022 | 1182 | 0.120 |
Why?
|
| Antigens, Bacterial | 3 | 1999 | 1141 | 0.120 |
Why?
|
| Male | 108 | 2022 | 360358 | 0.120 |
Why?
|
| Epithelial Cells | 8 | 2016 | 3672 | 0.120 |
Why?
|
| Citrobacter rodentium | 1 | 2015 | 65 | 0.120 |
Why?
|
| Immunohistochemistry | 22 | 2013 | 11069 | 0.120 |
Why?
|
| Radial Artery | 1 | 1996 | 187 | 0.120 |
Why?
|
| Heart Neoplasms | 1 | 1998 | 362 | 0.120 |
Why?
|
| Glomerulonephritis | 6 | 2015 | 331 | 0.120 |
Why?
|
| Clone Cells | 3 | 2005 | 1657 | 0.120 |
Why?
|
| Up-Regulation | 3 | 2003 | 4117 | 0.120 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2017 | 506 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2016 | 4341 | 0.120 |
Why?
|
| Cytotoxicity, Immunologic | 6 | 2019 | 1349 | 0.120 |
Why?
|
| Macrophage-1 Antigen | 2 | 1993 | 285 | 0.120 |
Why?
|
| Female | 120 | 2022 | 392148 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2018 | 569 | 0.110 |
Why?
|
| Histocytochemistry | 12 | 1998 | 696 | 0.110 |
Why?
|
| Receptors, IgE | 4 | 2008 | 375 | 0.110 |
Why?
|
| Hepatitis C | 4 | 2009 | 1579 | 0.110 |
Why?
|
| Th17 Cells | 3 | 2015 | 793 | 0.110 |
Why?
|
| Glycoproteins | 6 | 2013 | 2200 | 0.110 |
Why?
|
| Virus Replication | 1 | 2021 | 2427 | 0.110 |
Why?
|
| Antigen Presentation | 3 | 2012 | 1250 | 0.110 |
Why?
|
| Salmonella Infections, Animal | 1 | 2013 | 60 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 1201 | 0.110 |
Why?
|
| Wiskott-Aldrich Syndrome | 3 | 2011 | 131 | 0.110 |
Why?
|
| Oximetry | 1 | 1996 | 459 | 0.110 |
Why?
|
| Vascular Patency | 1 | 1996 | 911 | 0.110 |
Why?
|
| beta 2-Microglobulin | 6 | 1985 | 328 | 0.110 |
Why?
|
| Antigens, Neoplasm | 11 | 2000 | 1985 | 0.110 |
Why?
|
| Lymphocyte Count | 2 | 2013 | 778 | 0.100 |
Why?
|
| Adult | 81 | 2022 | 220969 | 0.100 |
Why?
|
| Hemangioendothelioma | 3 | 1993 | 111 | 0.100 |
Why?
|
| Liver Cirrhosis, Biliary | 3 | 1982 | 108 | 0.100 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1993 | 64 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 1390 | 0.100 |
Why?
|
| Middle Aged | 62 | 2022 | 220584 | 0.100 |
Why?
|
| Anti-Retroviral Agents | 1 | 2022 | 1782 | 0.100 |
Why?
|
| Hematologic Tests | 1 | 2013 | 239 | 0.100 |
Why?
|
| Lipopolysaccharides | 6 | 2018 | 2202 | 0.100 |
Why?
|
| Receptors, Interleukin | 1 | 2013 | 243 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 1936 | 0.100 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2011 | 39 | 0.100 |
Why?
|
| Membrane Proteins | 4 | 2016 | 7847 | 0.100 |
Why?
|
| Estrogens | 1 | 2018 | 1521 | 0.100 |
Why?
|
| Synovial Membrane | 4 | 2004 | 532 | 0.100 |
Why?
|
| Diagnosis, Differential | 13 | 2017 | 12966 | 0.100 |
Why?
|
| Antigens, Viral | 5 | 2022 | 987 | 0.100 |
Why?
|
| Adipose Tissue, Brown | 1 | 2017 | 762 | 0.100 |
Why?
|
| Bone Neoplasms | 6 | 1999 | 2527 | 0.100 |
Why?
|
| Hemangiosarcoma | 2 | 1993 | 215 | 0.100 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2004 | 289 | 0.090 |
Why?
|
| Leukemia, Lymphoid | 4 | 1986 | 310 | 0.090 |
Why?
|
| Estradiol | 1 | 2018 | 1937 | 0.090 |
Why?
|
| Graft Rejection | 8 | 2003 | 4446 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2022 | 1518 | 0.090 |
Why?
|
| DNA, Viral | 3 | 2023 | 2195 | 0.090 |
Why?
|
| Mycophenolic Acid | 1 | 2013 | 349 | 0.090 |
Why?
|
| Paget Disease, Extramammary | 1 | 1991 | 51 | 0.090 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2001 | 1228 | 0.090 |
Why?
|
| Carrier Proteins | 3 | 2014 | 4935 | 0.090 |
Why?
|
| Crohn Disease | 4 | 2014 | 2279 | 0.090 |
Why?
|
| Coronary Artery Bypass | 2 | 1997 | 2188 | 0.090 |
Why?
|
| Arthritis, Experimental | 1 | 2013 | 291 | 0.090 |
Why?
|
| Immunoglobulin A | 4 | 2009 | 978 | 0.090 |
Why?
|
| Glucocorticoids | 5 | 2015 | 2160 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 998 | 0.090 |
Why?
|
| Interleukin-12 | 2 | 2007 | 577 | 0.090 |
Why?
|
| Antigens, Differentiation | 2 | 2007 | 908 | 0.090 |
Why?
|
| Lysosomes | 1 | 2016 | 924 | 0.090 |
Why?
|
| Immunoglobulin E | 5 | 2002 | 1502 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 3150 | 0.090 |
Why?
|
| Plasmacytoma | 2 | 1985 | 171 | 0.090 |
Why?
|
| Microvilli | 2 | 2013 | 234 | 0.090 |
Why?
|
| Integrins | 1 | 1994 | 834 | 0.090 |
Why?
|
| Homeostasis | 4 | 2015 | 3321 | 0.090 |
Why?
|
| Diarrhea | 2 | 2014 | 1317 | 0.090 |
Why?
|
| Plant Lectins | 1 | 1990 | 103 | 0.090 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 390 | 0.090 |
Why?
|
| Helicobacter hepaticus | 1 | 2009 | 25 | 0.080 |
Why?
|
| Dysgerminoma | 2 | 1987 | 66 | 0.080 |
Why?
|
| Epithelium | 10 | 1997 | 1603 | 0.080 |
Why?
|
| Mice, Transgenic | 11 | 2007 | 9529 | 0.080 |
Why?
|
| Gliadin | 1 | 2009 | 80 | 0.080 |
Why?
|
| Immunoglobulins | 6 | 2002 | 850 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2015 | 2425 | 0.080 |
Why?
|
| Immunity, Innate | 5 | 2016 | 3045 | 0.080 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2009 | 306 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 14 | 1992 | 2467 | 0.080 |
Why?
|
| Aromatase Inhibitors | 1 | 2013 | 513 | 0.080 |
Why?
|
| Hyperplasia | 4 | 2015 | 1150 | 0.080 |
Why?
|
| Histocompatibility Antigens | 4 | 1988 | 464 | 0.080 |
Why?
|
| Neurofibroma | 1 | 1989 | 95 | 0.080 |
Why?
|
| Spleen | 11 | 2015 | 2286 | 0.080 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 510 | 0.080 |
Why?
|
| Aged | 43 | 2022 | 169042 | 0.080 |
Why?
|
| Hypersensitivity, Delayed | 7 | 1998 | 490 | 0.080 |
Why?
|
| Receptors, Chemokine | 3 | 2015 | 652 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 7 | 2007 | 2690 | 0.080 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 1997 | 544 | 0.080 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 344 | 0.080 |
Why?
|
| DNA Primers | 7 | 2013 | 2817 | 0.080 |
Why?
|
| Inhibins | 2 | 2000 | 210 | 0.080 |
Why?
|
| Autophagy | 2 | 2014 | 1326 | 0.080 |
Why?
|
| Monocytes | 5 | 2013 | 2565 | 0.080 |
Why?
|
| Hemangioma | 2 | 1993 | 727 | 0.080 |
Why?
|
| Amyloidosis | 1 | 2015 | 815 | 0.080 |
Why?
|
| Exanthema | 1 | 2013 | 503 | 0.080 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 1409 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 1250 | 0.080 |
Why?
|
| Intestine, Large | 1 | 2008 | 69 | 0.080 |
Why?
|
| Skin Neoplasms | 7 | 2012 | 5812 | 0.080 |
Why?
|
| Antibodies | 9 | 2008 | 2414 | 0.080 |
Why?
|
| AIDS-Related Complex | 1 | 1988 | 107 | 0.080 |
Why?
|
| Ultrasonography | 2 | 2018 | 5964 | 0.080 |
Why?
|
| Interleukin-2 | 4 | 2007 | 1887 | 0.080 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2000 | 221 | 0.080 |
Why?
|
| Blotting, Western | 5 | 2015 | 5034 | 0.080 |
Why?
|
| Chordoma | 3 | 1997 | 347 | 0.080 |
Why?
|
| HLA-DR Antigens | 8 | 1987 | 602 | 0.080 |
Why?
|
| Chondroblastoma | 2 | 1999 | 47 | 0.080 |
Why?
|
| Antibody Formation | 3 | 1994 | 1390 | 0.080 |
Why?
|
| Signal Transduction | 13 | 2016 | 23416 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 178 | 0.080 |
Why?
|
| Receptors, Complement 3d | 1 | 2008 | 117 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2018 | 2637 | 0.080 |
Why?
|
| Interleukins | 2 | 2015 | 783 | 0.070 |
Why?
|
| Nitriles | 1 | 2013 | 971 | 0.070 |
Why?
|
| Fontan Procedure | 3 | 2000 | 796 | 0.070 |
Why?
|
| Peritoneal Cavity | 1 | 2008 | 135 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 13635 | 0.070 |
Why?
|
| Immunoglobulin G | 9 | 2009 | 4533 | 0.070 |
Why?
|
| Mice, Inbred CBA | 7 | 2006 | 436 | 0.070 |
Why?
|
| Receptors, Interleukin-2 | 3 | 2004 | 561 | 0.070 |
Why?
|
| Testicular Neoplasms | 2 | 2000 | 800 | 0.070 |
Why?
|
| Peptides | 7 | 2000 | 4354 | 0.070 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1989 | 550 | 0.070 |
Why?
|
| Triazoles | 1 | 2013 | 903 | 0.070 |
Why?
|
| Liver Transplantation | 3 | 2004 | 2329 | 0.070 |
Why?
|
| North America | 2 | 2021 | 1273 | 0.070 |
Why?
|
| Antibody Specificity | 4 | 1998 | 1058 | 0.070 |
Why?
|
| Plasma Cells | 3 | 1996 | 597 | 0.070 |
Why?
|
| Mesentery | 2 | 1999 | 202 | 0.070 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 6 | 1997 | 317 | 0.070 |
Why?
|
| Alanine Transaminase | 4 | 2021 | 601 | 0.070 |
Why?
|
| Immunoglobulin mu-Chains | 2 | 1997 | 62 | 0.070 |
Why?
|
| STAT1 Transcription Factor | 1 | 2009 | 340 | 0.070 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2012 | 328 | 0.070 |
Why?
|
| Beta-Globulins | 3 | 1983 | 27 | 0.070 |
Why?
|
| Immunophenotyping | 5 | 2008 | 1865 | 0.070 |
Why?
|
| Skin Diseases | 3 | 1991 | 1094 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 1128 | 0.070 |
Why?
|
| Receptors, CCR4 | 1 | 2007 | 77 | 0.070 |
Why?
|
| Lymphopenia | 1 | 2009 | 281 | 0.070 |
Why?
|
| Clostridium Infections | 1 | 2014 | 557 | 0.070 |
Why?
|
| Gene Expression Regulation | 6 | 2016 | 11874 | 0.070 |
Why?
|
| DNA-Binding Proteins | 9 | 2014 | 9586 | 0.070 |
Why?
|
| Cell Movement | 10 | 2015 | 5200 | 0.070 |
Why?
|
| Molluscum Contagiosum | 1 | 1986 | 15 | 0.070 |
Why?
|
| Musculoskeletal Diseases | 1 | 1993 | 597 | 0.070 |
Why?
|
| Cells, Cultured | 10 | 2016 | 18937 | 0.070 |
Why?
|
| Lymphotoxin-alpha | 2 | 1998 | 93 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2007 | 704 | 0.070 |
Why?
|
| Inflammation Mediators | 3 | 2011 | 1884 | 0.070 |
Why?
|
| Receptors, Estrogen | 2 | 2013 | 2208 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2013 | 1503 | 0.070 |
Why?
|
| Cell Division | 6 | 2012 | 4457 | 0.070 |
Why?
|
| Condylomata Acuminata | 1 | 1986 | 75 | 0.070 |
Why?
|
| Nephritis | 2 | 1985 | 145 | 0.070 |
Why?
|
| Epidermis | 5 | 1990 | 527 | 0.070 |
Why?
|
| Warts | 1 | 1986 | 66 | 0.070 |
Why?
|
| Skin Diseases, Infectious | 1 | 1986 | 76 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 4570 | 0.070 |
Why?
|
| Rats | 20 | 2002 | 23717 | 0.070 |
Why?
|
| Lymphocyte Transfusion | 3 | 2011 | 232 | 0.070 |
Why?
|
| Ovalbumin | 6 | 2002 | 675 | 0.070 |
Why?
|
| Neutrophils | 4 | 2012 | 3763 | 0.070 |
Why?
|
| Protein Biosynthesis | 5 | 2022 | 2100 | 0.060 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 1988 | 709 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 3800 | 0.060 |
Why?
|
| Helicobacter Infections | 1 | 2009 | 387 | 0.060 |
Why?
|
| Cell Separation | 3 | 2008 | 1718 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2013 | 1799 | 0.060 |
Why?
|
| Fever | 1 | 2013 | 1618 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 578 | 0.060 |
Why?
|
| Cell Line | 12 | 2013 | 15576 | 0.060 |
Why?
|
| Cell Proliferation | 4 | 2015 | 10432 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 8 | 2002 | 6074 | 0.060 |
Why?
|
| Hepatitis C Antigens | 1 | 2005 | 34 | 0.060 |
Why?
|
| Skin Transplantation | 4 | 1994 | 1083 | 0.060 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 15828 | 0.060 |
Why?
|
| Biopsy | 8 | 2021 | 6762 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 14648 | 0.060 |
Why?
|
| Jejunal Neoplasms | 1 | 1985 | 19 | 0.060 |
Why?
|
| Reproducibility of Results | 6 | 2020 | 20074 | 0.060 |
Why?
|
| Pulmonary Alveoli | 2 | 1986 | 652 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 5 | 2000 | 1602 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 2 | 1998 | 552 | 0.060 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1639 | 0.060 |
Why?
|
| Skull Neoplasms | 2 | 1997 | 173 | 0.060 |
Why?
|
| Energy Intake | 1 | 2012 | 2132 | 0.060 |
Why?
|
| Indicators and Reagents | 2 | 2002 | 460 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 1997 | 647 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 1993 | 1890 | 0.060 |
Why?
|
| Desmin | 3 | 1999 | 99 | 0.060 |
Why?
|
| Molecular Weight | 6 | 1996 | 2185 | 0.060 |
Why?
|
| Neurilemmoma | 1 | 1989 | 524 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1998 | 888 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2017 | 3411 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 3356 | 0.060 |
Why?
|
| Tricuspid Atresia | 2 | 2001 | 37 | 0.060 |
Why?
|
| Heart Defects, Congenital | 5 | 2001 | 4671 | 0.060 |
Why?
|
| Allergens | 3 | 2002 | 1429 | 0.060 |
Why?
|
| Infant | 18 | 2013 | 36152 | 0.060 |
Why?
|
| Dexamethasone | 3 | 2022 | 1947 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2812 | 0.060 |
Why?
|
| Histiocytes | 1 | 1984 | 98 | 0.060 |
Why?
|
| Toxoplasmosis | 1 | 1984 | 94 | 0.060 |
Why?
|
| Mice, SCID | 5 | 2016 | 2625 | 0.050 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1985 | 382 | 0.050 |
Why?
|
| Models, Immunological | 1 | 2006 | 512 | 0.050 |
Why?
|
| Neoplasms | 6 | 2022 | 22131 | 0.050 |
Why?
|
| Immunization, Passive | 5 | 2001 | 616 | 0.050 |
Why?
|
| Adolescent | 23 | 2021 | 88234 | 0.050 |
Why?
|
| Immunosuppressive Agents | 3 | 2013 | 4174 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 2 | 2009 | 1614 | 0.050 |
Why?
|
| Lymphadenitis | 1 | 1984 | 99 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 1986 | 465 | 0.050 |
Why?
|
| Trophoblasts | 1 | 1985 | 224 | 0.050 |
Why?
|
| Carcinoma | 4 | 1995 | 2327 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2005 | 211 | 0.050 |
Why?
|
| Recombinant Proteins | 6 | 2006 | 6520 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 1985 | 270 | 0.050 |
Why?
|
| Autoantigens | 2 | 1997 | 888 | 0.050 |
Why?
|
| Hydatidiform Mole | 1 | 1985 | 255 | 0.050 |
Why?
|
| Encephalitis | 1 | 1986 | 438 | 0.050 |
Why?
|
| Viral Load | 4 | 2022 | 3325 | 0.050 |
Why?
|
| RNA, Viral | 4 | 2021 | 2838 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 4 | 2004 | 1963 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 2895 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2022 | 111 | 0.050 |
Why?
|
| Lectins | 3 | 1997 | 489 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 244 | 0.050 |
Why?
|
| Pulmonary Fibrosis | 1 | 1986 | 505 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 2864 | 0.050 |
Why?
|
| Immunization | 6 | 2004 | 1217 | 0.050 |
Why?
|
| Genes, RAG-1 | 2 | 2002 | 67 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2006 | 963 | 0.050 |
Why?
|
| CD40 Ligand | 2 | 2001 | 521 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 871 | 0.050 |
Why?
|
| Uterine Neoplasms | 2 | 1995 | 1420 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 1517 | 0.050 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 1997 | 547 | 0.050 |
Why?
|
| Receptors, Fc | 3 | 1997 | 534 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2013 | 5110 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 3 | 1976 | 835 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 8998 | 0.050 |
Why?
|
| Autoimmunity | 2 | 2007 | 1350 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 310 | 0.050 |
Why?
|
| Conjunctival Diseases | 1 | 1982 | 110 | 0.050 |
Why?
|
| Precipitin Tests | 3 | 1994 | 813 | 0.050 |
Why?
|
| Antimetabolites | 1 | 2002 | 129 | 0.050 |
Why?
|
| S100 Proteins | 5 | 1999 | 217 | 0.050 |
Why?
|
| Crosses, Genetic | 2 | 2006 | 750 | 0.050 |
Why?
|
| Leukocyte Count | 5 | 2004 | 1597 | 0.050 |
Why?
|
| Vimentin | 3 | 1994 | 255 | 0.050 |
Why?
|
| Antigens, CD1d | 1 | 2002 | 228 | 0.050 |
Why?
|
| Carcinoembryonic Antigen | 4 | 1999 | 335 | 0.050 |
Why?
|
| Lichen Planus | 1 | 1981 | 70 | 0.050 |
Why?
|
| Gene Expression | 4 | 2003 | 7568 | 0.050 |
Why?
|
| Physical Exertion | 2 | 1975 | 668 | 0.050 |
Why?
|
| Palatine Tonsil | 3 | 1996 | 193 | 0.050 |
Why?
|
| Sarcoma, Experimental | 1 | 1981 | 116 | 0.050 |
Why?
|
| Triazines | 1 | 1983 | 311 | 0.050 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2000 | 33 | 0.050 |
Why?
|
| Antibody Diversity | 1 | 2000 | 72 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 908 | 0.050 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2022 | 225 | 0.050 |
Why?
|
| Basement Membrane | 5 | 1993 | 349 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2022 | 385 | 0.040 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2005 | 557 | 0.040 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2001 | 188 | 0.040 |
Why?
|
| Ovarian Neoplasms | 6 | 1998 | 4849 | 0.040 |
Why?
|
| Cricetinae | 3 | 2002 | 2424 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2002 | 2852 | 0.040 |
Why?
|
| Drug Therapy, Combination | 4 | 2021 | 6305 | 0.040 |
Why?
|
| Guanine | 1 | 2021 | 278 | 0.040 |
Why?
|
| Disease Progression | 3 | 2021 | 13495 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 3 | 2015 | 2063 | 0.040 |
Why?
|
| Cadherins | 1 | 2004 | 901 | 0.040 |
Why?
|
| Lamivudine | 1 | 2021 | 366 | 0.040 |
Why?
|
| Ethanol | 2 | 2017 | 1320 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 344 | 0.040 |
Why?
|
| Pulmonary Artery | 2 | 2000 | 1927 | 0.040 |
Why?
|
| Fetus | 3 | 1997 | 1862 | 0.040 |
Why?
|
| Endothelium | 5 | 1994 | 764 | 0.040 |
Why?
|
| Breast Neoplasms | 4 | 2013 | 20988 | 0.040 |
Why?
|
| HIV | 2 | 2022 | 1579 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2004 | 965 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 2000 | 257 | 0.040 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2001 | 172 | 0.040 |
Why?
|
| Leukemia, Experimental | 1 | 1979 | 225 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1988 | 2197 | 0.040 |
Why?
|
| Stem Cells | 1 | 2012 | 3516 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2022 | 368 | 0.040 |
Why?
|
| Helicobacter | 1 | 1999 | 111 | 0.040 |
Why?
|
| Rats, Inbred Lew | 4 | 1988 | 1157 | 0.040 |
Why?
|
| Peyer's Patches | 2 | 1996 | 120 | 0.040 |
Why?
|
| Rabbits | 5 | 2015 | 4770 | 0.040 |
Why?
|
| Conjunctiva | 1 | 1982 | 479 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2019 | 4512 | 0.040 |
Why?
|
| Mucin-1 | 3 | 1994 | 538 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2005 | 1079 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2004 | 542 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2016 | 3087 | 0.040 |
Why?
|
| Ligands | 4 | 2011 | 3268 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2004 | 1294 | 0.040 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 1998 | 75 | 0.040 |
Why?
|
| Cell Adhesion | 3 | 2004 | 3088 | 0.040 |
Why?
|
| Rats, Inbred Strains | 3 | 1990 | 2088 | 0.040 |
Why?
|
| Apoptosis | 6 | 2016 | 9476 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 1999 | 269 | 0.040 |
Why?
|
| Killer Cells, Natural | 2 | 2000 | 2191 | 0.040 |
Why?
|
| Administration, Oral | 3 | 2014 | 4010 | 0.040 |
Why?
|
| Neoplasm Transplantation | 3 | 2017 | 2010 | 0.040 |
Why?
|
| Rats, Inbred WKY | 2 | 2015 | 150 | 0.040 |
Why?
|
| Treatment Outcome | 10 | 2021 | 64568 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2004 | 944 | 0.040 |
Why?
|
| Endometrium | 2 | 1995 | 403 | 0.040 |
Why?
|
| Cornea | 2 | 2004 | 1332 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2018 | 151 | 0.040 |
Why?
|
| Goblet Cells | 2 | 2014 | 298 | 0.040 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2021 | 621 | 0.040 |
Why?
|
| Phagocytes | 2 | 2015 | 295 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2000 | 486 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 1033 | 0.040 |
Why?
|
| Camelids, New World | 1 | 2017 | 20 | 0.040 |
Why?
|
| Isoflavones | 1 | 2018 | 136 | 0.040 |
Why?
|
| Concanavalin A | 3 | 1998 | 190 | 0.040 |
Why?
|
| Uveitis | 1 | 2001 | 396 | 0.040 |
Why?
|
| Enterobacteriaceae | 1 | 1999 | 161 | 0.040 |
Why?
|
| Prospective Studies | 6 | 2021 | 54360 | 0.040 |
Why?
|
| Child, Preschool | 16 | 2016 | 42188 | 0.040 |
Why?
|
| Mutation | 7 | 2016 | 30016 | 0.040 |
Why?
|
| RNA, Messenger | 7 | 2002 | 12758 | 0.040 |
Why?
|
| Base Sequence | 7 | 2012 | 12421 | 0.040 |
Why?
|
| Cell Extracts | 1 | 1997 | 135 | 0.040 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2018 | 133 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2022 | 879 | 0.040 |
Why?
|
| Triglycerides | 2 | 2017 | 2459 | 0.040 |
Why?
|
| Immunoglobulin Fragments | 1 | 2017 | 84 | 0.040 |
Why?
|
| alpha 1-Antichymotrypsin | 2 | 1995 | 19 | 0.040 |
Why?
|
| Chondrosarcoma, Mesenchymal | 1 | 1996 | 12 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 363 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2001 | 1835 | 0.040 |
Why?
|
| Transducers | 1 | 2018 | 244 | 0.040 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 1997 | 38 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 427 | 0.030 |
Why?
|
| Postoperative Complications | 7 | 2001 | 15612 | 0.030 |
Why?
|
| Joint Diseases | 2 | 1971 | 459 | 0.030 |
Why?
|
| Heart Ventricles | 2 | 2001 | 3796 | 0.030 |
Why?
|
| Mice, Inbred Strains | 6 | 2000 | 1759 | 0.030 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 1997 | 91 | 0.030 |
Why?
|
| Bronchial Hyperreactivity | 1 | 1998 | 302 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 3 | 1986 | 340 | 0.030 |
Why?
|
| Urethral Neoplasms | 1 | 1996 | 37 | 0.030 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2016 | 28 | 0.030 |
Why?
|
| Genes, bcl-2 | 1 | 1997 | 119 | 0.030 |
Why?
|
| Nephritis, Interstitial | 3 | 1986 | 155 | 0.030 |
Why?
|
| Bone Marrow | 3 | 1995 | 2909 | 0.030 |
Why?
|
| Cranial Fossa, Posterior | 1 | 1997 | 135 | 0.030 |
Why?
|
| Urethral Diseases | 1 | 1996 | 52 | 0.030 |
Why?
|
| Endolymphatic Sac | 1 | 1997 | 49 | 0.030 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1999 | 574 | 0.030 |
Why?
|
| Polymorphism, Genetic | 2 | 2018 | 4242 | 0.030 |
Why?
|
| Shear Strength | 1 | 2017 | 160 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2004 | 4137 | 0.030 |
Why?
|
| Receptors, Complement | 3 | 1997 | 253 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 14018 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2022 | 858 | 0.030 |
Why?
|
| Tropomyosin | 1 | 1996 | 104 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2007 | 3206 | 0.030 |
Why?
|
| Hepatic Stellate Cells | 1 | 2017 | 119 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2017 | 211 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2016 | 190 | 0.030 |
Why?
|
| Papilloma | 1 | 1997 | 140 | 0.030 |
Why?
|
| Child | 20 | 2001 | 80079 | 0.030 |
Why?
|
| Pulmonary Veins | 1 | 2001 | 716 | 0.030 |
Why?
|
| alpha 1-Antitrypsin | 2 | 1993 | 167 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 2001 | 526 | 0.030 |
Why?
|
| Guinea Pigs | 7 | 1984 | 1310 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2001 | 1835 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 561 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2022 | 1810 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1788 | 0.030 |
Why?
|
| RNA | 2 | 2022 | 2713 | 0.030 |
Why?
|
| Pyelonephritis | 2 | 1988 | 75 | 0.030 |
Why?
|
| Sheep | 1 | 2018 | 1436 | 0.030 |
Why?
|
| Harmine | 1 | 2015 | 11 | 0.030 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1996 | 158 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2001 | 753 | 0.030 |
Why?
|
| Antigens, Ly | 3 | 2000 | 294 | 0.030 |
Why?
|
| Chemokines, CXC | 1 | 1997 | 416 | 0.030 |
Why?
|
| Molecular Mimicry | 1 | 1996 | 213 | 0.030 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1995 | 162 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 876 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 7402 | 0.030 |
Why?
|
| Nitrogen Oxides | 1 | 1995 | 129 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2017 | 214 | 0.030 |
Why?
|
| Lymphocyte Cooperation | 3 | 2004 | 112 | 0.030 |
Why?
|
| Mesenchymoma | 1 | 1995 | 49 | 0.030 |
Why?
|
| Chondrosarcoma | 2 | 1997 | 295 | 0.030 |
Why?
|
| Prealbumin | 1 | 1997 | 222 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11736 | 0.030 |
Why?
|
| Erythema Multiforme | 2 | 1986 | 31 | 0.030 |
Why?
|
| Blood | 1 | 1997 | 596 | 0.030 |
Why?
|
| Liver Neoplasms | 3 | 2007 | 4308 | 0.030 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 1976 | 112 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 721 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2016 | 299 | 0.030 |
Why?
|
| Phagosomes | 1 | 2016 | 199 | 0.030 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2016 | 302 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 1984 | 2821 | 0.030 |
Why?
|
| Risk | 2 | 2018 | 9604 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 4 | 1996 | 2894 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2007 | 2291 | 0.030 |
Why?
|
| Carcinosarcoma | 1 | 1995 | 106 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 15908 | 0.030 |
Why?
|
| Mast Cells | 1 | 2002 | 1392 | 0.030 |
Why?
|
| Peroxidase | 2 | 2011 | 610 | 0.030 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 3 | 1984 | 823 | 0.030 |
Why?
|
| Streptomycin | 1 | 2014 | 69 | 0.030 |
Why?
|
| Antigens, CD7 | 1 | 1994 | 29 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1996 | 816 | 0.030 |
Why?
|
| Aging | 5 | 2022 | 8699 | 0.030 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 1994 | 90 | 0.030 |
Why?
|
| Leukocytes | 3 | 2007 | 2023 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 1997 | 696 | 0.030 |
Why?
|
| Enterocolitis | 1 | 2015 | 106 | 0.030 |
Why?
|
| Vestibular Diseases | 1 | 1997 | 231 | 0.030 |
Why?
|
| Kidney Tubules | 4 | 1987 | 449 | 0.030 |
Why?
|
| Bacteremia | 1 | 2001 | 977 | 0.030 |
Why?
|
| Caspases | 1 | 1997 | 878 | 0.030 |
Why?
|
| Adenoids | 1 | 1993 | 35 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 1098 | 0.030 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 1993 | 35 | 0.030 |
Why?
|
| Rosette Formation | 1 | 1993 | 152 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1879 | 0.030 |
Why?
|
| Myosins | 1 | 1975 | 404 | 0.030 |
Why?
|
| Complement C3b | 1 | 1993 | 97 | 0.030 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 1995 | 140 | 0.030 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1993 | 317 | 0.030 |
Why?
|
| Absorption | 1 | 2013 | 242 | 0.030 |
Why?
|
| Aged, 80 and over | 8 | 2017 | 58894 | 0.030 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2013 | 82 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2018 | 1006 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1336 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1995 | 685 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1993 | 317 | 0.030 |
Why?
|
| Arteriosclerosis | 1 | 1997 | 1056 | 0.030 |
Why?
|
| Chemokine CCL7 | 1 | 2012 | 30 | 0.030 |
Why?
|
| Neoplasm Proteins | 2 | 2000 | 3607 | 0.030 |
Why?
|
| Myocardium | 3 | 1976 | 4724 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2012 | 3591 | 0.030 |
Why?
|
| Azo Compounds | 1 | 2013 | 117 | 0.030 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2012 | 38 | 0.030 |
Why?
|
| Appendectomy | 1 | 1996 | 433 | 0.030 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2012 | 16 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 2379 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 420 | 0.030 |
Why?
|
| Genes, MHC Class II | 1 | 1993 | 433 | 0.030 |
Why?
|
| Cross-Priming | 1 | 2012 | 76 | 0.030 |
Why?
|
| Histiocytosis, Langerhans-Cell | 3 | 1983 | 169 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2000 | 2661 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 1997 | 980 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2004 | 2668 | 0.030 |
Why?
|
| Cell Transformation, Viral | 2 | 1985 | 526 | 0.030 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 2231 | 0.030 |
Why?
|
| Antibodies, Neoplasm | 2 | 1984 | 280 | 0.030 |
Why?
|
| Sialyltransferases | 1 | 2012 | 83 | 0.030 |
Why?
|
| Immunologic Memory | 3 | 2005 | 1355 | 0.030 |
Why?
|
| Treatment Failure | 3 | 2009 | 2635 | 0.030 |
Why?
|
| Nasal Mucosa | 2 | 1993 | 415 | 0.020 |
Why?
|
| Fucosyltransferases | 1 | 2012 | 117 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2013 | 619 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 1996 | 868 | 0.020 |
Why?
|
| Nuclear Proteins | 2 | 2004 | 5789 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2000 | 17629 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2016 | 1755 | 0.020 |
Why?
|
| Sarcoma | 2 | 1996 | 1800 | 0.020 |
Why?
|
| Genotype | 4 | 2012 | 12978 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2017 | 1674 | 0.020 |
Why?
|
| Hepatitis C Antibodies | 2 | 2004 | 146 | 0.020 |
Why?
|
| Nose Neoplasms | 2 | 1990 | 249 | 0.020 |
Why?
|
| Mice, Nude | 4 | 2009 | 3605 | 0.020 |
Why?
|
| Prednisolone | 2 | 2003 | 325 | 0.020 |
Why?
|
| Patient Selection | 2 | 2001 | 4237 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 1997 | 735 | 0.020 |
Why?
|
| Integrin alpha Chains | 1 | 2011 | 95 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2016 | 526 | 0.020 |
Why?
|
| Melanoma | 3 | 1998 | 5697 | 0.020 |
Why?
|
| Young Adult | 4 | 2021 | 59179 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 3447 | 0.020 |
Why?
|
| Hemosiderin | 1 | 1971 | 41 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2017 | 1163 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 1997 | 1085 | 0.020 |
Why?
|
| Lymphokines | 2 | 1984 | 925 | 0.020 |
Why?
|
| Bacteria | 1 | 2022 | 2192 | 0.020 |
Why?
|
| Cytoplasmic Granules | 4 | 1990 | 573 | 0.020 |
Why?
|
| Protein Conformation | 2 | 2015 | 3965 | 0.020 |
Why?
|
| gamma-Globulins | 4 | 1978 | 119 | 0.020 |
Why?
|
| Cancer Vaccines | 1 | 1998 | 1037 | 0.020 |
Why?
|
| Gene Targeting | 1 | 1994 | 837 | 0.020 |
Why?
|
| Lymphoma, Follicular | 2 | 1985 | 457 | 0.020 |
Why?
|
| Nose Deformities, Acquired | 1 | 1971 | 44 | 0.020 |
Why?
|
| Actuarial Analysis | 2 | 2001 | 372 | 0.020 |
Why?
|
| Radiation Chimera | 2 | 2001 | 215 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2016 | 1132 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2012 | 277 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2012 | 469 | 0.020 |
Why?
|
| Phenotype | 7 | 2003 | 16571 | 0.020 |
Why?
|
| Kinetics | 5 | 1991 | 6370 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2000 | 13441 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2015 | 1697 | 0.020 |
Why?
|
| Bioprosthesis | 1 | 1995 | 591 | 0.020 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1991 | 138 | 0.020 |
Why?
|
| Multivariate Analysis | 3 | 2013 | 12043 | 0.020 |
Why?
|
| Eosinophils | 3 | 2001 | 953 | 0.020 |
Why?
|
| Adenine | 1 | 2016 | 985 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 982 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1994 | 829 | 0.020 |
Why?
|
| Transplantation, Homologous | 5 | 1995 | 4804 | 0.020 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1991 | 133 | 0.020 |
Why?
|
| Hemangiopericytoma | 1 | 1990 | 71 | 0.020 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 1991 | 88 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 1988 | 0.020 |
Why?
|
| Gene Transfer Techniques | 2 | 2008 | 1202 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2017 | 1231 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2004 | 3954 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 602 | 0.020 |
Why?
|
| Histological Techniques | 2 | 1986 | 194 | 0.020 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 1989 | 16 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2018 | 2518 | 0.020 |
Why?
|
| Kidney Transplantation | 3 | 1998 | 4236 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2012 | 299 | 0.020 |
Why?
|
| Time Factors | 9 | 2011 | 39913 | 0.020 |
Why?
|
| Duodenitis | 1 | 2009 | 20 | 0.020 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2009 | 65 | 0.020 |
Why?
|
| Autoradiography | 2 | 1984 | 728 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1994 | 1878 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2013 | 6807 | 0.020 |
Why?
|
| Laryngeal Neoplasms | 2 | 1995 | 514 | 0.020 |
Why?
|
| Tetralogy of Fallot | 1 | 1995 | 618 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1999 | 2234 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 1993 | 483 | 0.020 |
Why?
|
| Reference Values | 2 | 2013 | 4919 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 6126 | 0.020 |
Why?
|
| Rectal Prolapse | 1 | 2009 | 33 | 0.020 |
Why?
|
| Prolactinoma | 1 | 1990 | 114 | 0.020 |
Why?
|
| Follow-Up Studies | 7 | 2001 | 39063 | 0.020 |
Why?
|
| Dermoid Cyst | 1 | 1990 | 92 | 0.020 |
Why?
|
| Hyperprolactinemia | 1 | 1990 | 124 | 0.020 |
Why?
|
| Pyrroles | 1 | 1995 | 1125 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2013 | 9277 | 0.020 |
Why?
|
| Leukemoid Reaction | 1 | 1988 | 18 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2012 | 825 | 0.020 |
Why?
|
| Immune System | 1 | 1994 | 791 | 0.020 |
Why?
|
| Granulosa Cell Tumor | 2 | 2000 | 77 | 0.020 |
Why?
|
| Hypertension | 1 | 2009 | 8529 | 0.020 |
Why?
|
| Neoplasm Staging | 3 | 2013 | 11116 | 0.020 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 2 | 2000 | 84 | 0.020 |
Why?
|
| Mucous Membrane | 2 | 2007 | 659 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2392 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4269 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2013 | 1129 | 0.020 |
Why?
|
| Genetic Complementation Test | 2 | 2002 | 555 | 0.020 |
Why?
|
| Choristoma | 1 | 1990 | 205 | 0.020 |
Why?
|
| Age Factors | 3 | 2021 | 18381 | 0.020 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 1990 | 242 | 0.020 |
Why?
|
| HLA-D Antigens | 1 | 2008 | 129 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1995 | 1528 | 0.020 |
Why?
|
| von Willebrand Factor | 2 | 1990 | 676 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 2 | 1985 | 1077 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 2005 | 9026 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 1074 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 1835 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 1130 | 0.020 |
Why?
|
| Esterases | 2 | 1985 | 98 | 0.020 |
Why?
|
| Vincristine | 1 | 1970 | 1036 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 1624 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1186 | 0.020 |
Why?
|
| Wasting Syndrome | 2 | 1998 | 96 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 1985 | 1372 | 0.020 |
Why?
|
| HIV-1 | 1 | 2005 | 6858 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 1662 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2012 | 899 | 0.020 |
Why?
|
| Piperidines | 1 | 2016 | 1655 | 0.020 |
Why?
|
| Orchitis | 1 | 1987 | 35 | 0.020 |
Why?
|
| Receptors, Calcitonin | 1 | 1987 | 34 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 1994 | 703 | 0.020 |
Why?
|
| Histones | 1 | 1997 | 2577 | 0.020 |
Why?
|
| Sebaceous Glands | 2 | 1984 | 42 | 0.020 |
Why?
|
| Recurrence | 3 | 2004 | 8426 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 1990 | 635 | 0.020 |
Why?
|
| Glutens | 1 | 2009 | 240 | 0.020 |
Why?
|
| Paraganglioma | 1 | 1988 | 142 | 0.020 |
Why?
|
| Alleles | 1 | 1998 | 6861 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1988 | 224 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2016 | 1365 | 0.020 |
Why?
|
| Diet, Gluten-Free | 1 | 2009 | 283 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1988 | 242 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 1991 | 503 | 0.020 |
Why?
|
| Acute Disease | 5 | 2003 | 7237 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 472 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1985 | 1738 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 1986 | 60 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 1995 | 1462 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3868 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 476 | 0.020 |
Why?
|
| Adenoma | 1 | 1997 | 2159 | 0.020 |
Why?
|
| Chemistry, Physical | 1 | 1986 | 154 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 1988 | 420 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1985 | 116 | 0.020 |
Why?
|
| Staining and Labeling | 2 | 1986 | 1081 | 0.020 |
Why?
|
| Mucus | 1 | 2008 | 342 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1990 | 592 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2018 | 8618 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1118 | 0.020 |
Why?
|
| Immunotherapy | 3 | 2017 | 4642 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1986 | 506 | 0.020 |
Why?
|
| Prostatic Neoplasms | 2 | 1988 | 11106 | 0.020 |
Why?
|
| Thoracic Duct | 1 | 1986 | 64 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2016 | 2008 | 0.020 |
Why?
|
| Calcitonin | 1 | 1987 | 329 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 1999 | 563 | 0.020 |
Why?
|
| Retrospective Studies | 8 | 2013 | 80566 | 0.020 |
Why?
|
| Premedication | 1 | 1986 | 245 | 0.020 |
Why?
|
| Hematopoiesis | 3 | 2002 | 2049 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 1986 | 432 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 1525 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1985 | 169 | 0.020 |
Why?
|
| Lectins, C-Type | 2 | 2000 | 584 | 0.020 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 1988 | 262 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 1988 | 376 | 0.020 |
Why?
|
| Frozen Sections | 1 | 1986 | 153 | 0.020 |
Why?
|
| Sirolimus | 1 | 2012 | 1533 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2013 | 22148 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 3730 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2007 | 392 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 1991 | 2382 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 15251 | 0.020 |
Why?
|
| Dendrites | 2 | 1985 | 471 | 0.010 |
Why?
|
| Leg | 1 | 1990 | 1087 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1985 | 212 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2004 | 3752 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3514 | 0.010 |
Why?
|
| Mucinosis, Follicular | 1 | 1984 | 8 | 0.010 |
Why?
|
| Pityriasis | 1 | 1984 | 10 | 0.010 |
Why?
|
| Logistic Models | 2 | 2013 | 13245 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 26049 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 1988 | 518 | 0.010 |
Why?
|
| Genes, erbB-2 | 1 | 2005 | 162 | 0.010 |
Why?
|
| Longevity | 1 | 2012 | 1064 | 0.010 |
Why?
|
| Vaccination | 1 | 1997 | 3370 | 0.010 |
Why?
|
| Granulocytes | 1 | 1986 | 551 | 0.010 |
Why?
|
| Risk Factors | 5 | 2021 | 74115 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5672 | 0.010 |
Why?
|
| Candida | 1 | 2005 | 171 | 0.010 |
Why?
|
| Down-Regulation | 2 | 2003 | 2915 | 0.010 |
Why?
|
| Cystadenocarcinoma | 1 | 1983 | 54 | 0.010 |
Why?
|
| Kidney | 5 | 1993 | 7045 | 0.010 |
Why?
|
| Adenofibroma | 1 | 1983 | 25 | 0.010 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2004 | 144 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2005 | 913 | 0.010 |
Why?
|
| Apocrine Glands | 1 | 1983 | 32 | 0.010 |
Why?
|
| Tonometry, Ocular | 1 | 2004 | 235 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2016 | 3027 | 0.010 |
Why?
|
| Naphthol AS D Esterase | 1 | 1983 | 14 | 0.010 |
Why?
|
| Afghanistan | 1 | 1983 | 77 | 0.010 |
Why?
|
| Infant, Newborn | 5 | 2001 | 26180 | 0.010 |
Why?
|
| Eccrine Glands | 1 | 1983 | 52 | 0.010 |
Why?
|
| Immunologic Capping | 2 | 1998 | 30 | 0.010 |
Why?
|
| Hair | 2 | 1984 | 498 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2004 | 174 | 0.010 |
Why?
|
| Interphase | 2 | 1999 | 227 | 0.010 |
Why?
|
| Regeneration | 1 | 2012 | 1505 | 0.010 |
Why?
|
| Hand | 1 | 1988 | 902 | 0.010 |
Why?
|
| Complement System Proteins | 3 | 1985 | 734 | 0.010 |
Why?
|
| Mesonephroma | 1 | 1982 | 21 | 0.010 |
Why?
|
| Bone Marrow Cells | 3 | 1997 | 2409 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 2057 | 0.010 |
Why?
|
| Hepatitis A | 1 | 1983 | 128 | 0.010 |
Why?
|
| Complement C3 | 3 | 1984 | 434 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2004 | 249 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2011 | 2764 | 0.010 |
Why?
|
| HLA-C Antigens | 1 | 1983 | 140 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2003 | 91 | 0.010 |
Why?
|
| Lymphocyte Depletion | 2 | 1997 | 602 | 0.010 |
Why?
|
| Keratoconus | 1 | 2004 | 112 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2002 | 38 | 0.010 |
Why?
|
| Neprilysin | 1 | 1985 | 478 | 0.010 |
Why?
|
| HLA-A Antigens | 1 | 1983 | 223 | 0.010 |
Why?
|
| Photosensitivity Disorders | 1 | 1983 | 80 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1987 | 1463 | 0.010 |
Why?
|
| Immune Sera | 2 | 1984 | 605 | 0.010 |
Why?
|
| Enterotoxins | 1 | 2004 | 366 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2002 | 56 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2013 | 2553 | 0.010 |
Why?
|
| Ethanolamines | 1 | 1983 | 153 | 0.010 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2004 | 103 | 0.010 |
Why?
|
| Graft vs Host Reaction | 1 | 1982 | 99 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1990 | 1248 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 12116 | 0.010 |
Why?
|
| Placenta | 2 | 1997 | 1709 | 0.010 |
Why?
|
| Prognosis | 3 | 2013 | 29600 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2002 | 3394 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 517 | 0.010 |
Why?
|
| Ovary | 2 | 1983 | 959 | 0.010 |
Why?
|
| Mesencephalon | 1 | 1984 | 333 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1984 | 1376 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 1983 | 317 | 0.010 |
Why?
|
| Genetic Engineering | 2 | 1998 | 931 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1983 | 532 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 16967 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 2001 | 88 | 0.010 |
Why?
|
| Orbital Diseases | 1 | 1984 | 178 | 0.010 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1984 | 290 | 0.010 |
Why?
|
| Glioma | 1 | 1997 | 3453 | 0.010 |
Why?
|
| Tissue Distribution | 3 | 1993 | 2261 | 0.010 |
Why?
|
| Orbital Neoplasms | 1 | 1984 | 222 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1985 | 794 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 414 | 0.010 |
Why?
|
| Serum Albumin | 2 | 1983 | 672 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 1985 | 558 | 0.010 |
Why?
|
| Atropine | 1 | 2001 | 244 | 0.010 |
Why?
|
| Methylcholanthrene | 1 | 1981 | 30 | 0.010 |
Why?
|
| Tuberculosis, Osteoarticular | 2 | 1971 | 26 | 0.010 |
Why?
|
| Conjunctivitis | 1 | 1982 | 155 | 0.010 |
Why?
|
| Heart Bypass, Right | 1 | 2001 | 75 | 0.010 |
Why?
|
| Solubility | 1 | 1983 | 1089 | 0.010 |
Why?
|
| Ulcer | 1 | 1982 | 203 | 0.010 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 1981 | 42 | 0.010 |
Why?
|
| Hodgkin Disease | 2 | 1982 | 1378 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6483 | 0.010 |
Why?
|
| Nevus | 1 | 1982 | 205 | 0.010 |
Why?
|
| Antilymphocyte Serum | 1 | 1982 | 487 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2000 | 66 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2004 | 705 | 0.010 |
Why?
|
| Proteomics | 1 | 2014 | 3836 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 1984 | 1405 | 0.010 |
Why?
|
| Actins | 2 | 1999 | 2050 | 0.010 |
Why?
|
| Protein Binding | 2 | 2002 | 9345 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1986 | 2218 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 1900 | 0.010 |
Why?
|
| Breast Diseases | 1 | 1983 | 443 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 1982 | 335 | 0.010 |
Why?
|
| Retroviridae | 1 | 2002 | 851 | 0.010 |
Why?
|
| Nandrolone | 1 | 1979 | 16 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 2002 | 594 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 927 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 836 | 0.010 |
Why?
|
| Chromogranins | 1 | 2000 | 160 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2001 | 703 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 1986 | 828 | 0.010 |
Why?
|
| Alopecia | 1 | 1984 | 412 | 0.010 |
Why?
|
| Neutrophil Activation | 1 | 2000 | 180 | 0.010 |
Why?
|
| T-Box Domain Proteins | 1 | 2002 | 469 | 0.010 |
Why?
|
| Drug Carriers | 1 | 2004 | 706 | 0.010 |
Why?
|
| Synovitis | 2 | 1971 | 217 | 0.010 |
Why?
|
| Galactosyltransferases | 1 | 2001 | 276 | 0.010 |
Why?
|
| Cytoplasm | 2 | 1996 | 1503 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2000 | 214 | 0.010 |
Why?
|
| Giant Cell Arteritis | 1 | 1983 | 306 | 0.010 |
Why?
|
| Hepatitis | 1 | 1981 | 228 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 1687 | 0.010 |
Why?
|
| Weight Gain | 1 | 2009 | 2350 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 1991 | 3028 | 0.010 |
Why?
|
| Viral Core Proteins | 1 | 1999 | 161 | 0.010 |
Why?
|
| Gonadoblastoma | 1 | 1998 | 14 | 0.010 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1979 | 141 | 0.010 |
Why?
|
| Protein Interaction Mapping | 1 | 2002 | 615 | 0.010 |
Why?
|
| Sertoli-Leydig Cell Tumor | 1 | 1998 | 19 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2001 | 552 | 0.010 |
Why?
|
| Pregnancy | 3 | 1985 | 29868 | 0.010 |
Why?
|
| Epididymis | 1 | 2000 | 227 | 0.010 |
Why?
|
| Muridae | 1 | 1998 | 56 | 0.010 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 1998 | 131 | 0.010 |
Why?
|
| STAT4 Transcription Factor | 1 | 1998 | 93 | 0.010 |
Why?
|
| Carrier State | 1 | 1982 | 522 | 0.010 |
Why?
|
| Perforin | 1 | 1998 | 166 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1998 | 357 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2002 | 1490 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1998 | 216 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 1998 | 220 | 0.010 |
Why?
|
| Fibrosis | 1 | 2005 | 2045 | 0.010 |
Why?
|
| Reoperation | 2 | 2001 | 4300 | 0.010 |
Why?
|
| Orthomyxoviridae | 1 | 1999 | 149 | 0.010 |
Why?
|
| Chemokine CXCL5 | 1 | 1997 | 27 | 0.010 |
Why?
|
| Caspase 6 | 1 | 1997 | 15 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 1340 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 1998 | 613 | 0.010 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1997 | 93 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1997 | 68 | 0.010 |
Why?
|
| Caspase 7 | 1 | 1997 | 50 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1988 | 1662 | 0.010 |
Why?
|
| Adnexal Diseases | 1 | 1998 | 104 | 0.010 |
Why?
|
| Interleukin-15 | 1 | 1998 | 185 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 1997 | 170 | 0.010 |
Why?
|
| Collagen | 1 | 1985 | 2634 | 0.010 |
Why?
|
| Urticaria | 1 | 1978 | 150 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 3074 | 0.010 |
Why?
|
| Myelin Sheath | 2 | 1991 | 653 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 1999 | 658 | 0.010 |
Why?
|
| S Phase | 1 | 1998 | 421 | 0.010 |
Why?
|
| Fibroma | 1 | 1998 | 190 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1997 | 188 | 0.010 |
Why?
|
| Viral Vaccines | 1 | 1982 | 595 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2002 | 974 | 0.010 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 1998 | 118 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2005 | 1894 | 0.010 |
Why?
|
| Survival Rate | 2 | 2001 | 12719 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1997 | 510 | 0.010 |
Why?
|
| Prostate | 1 | 1984 | 1773 | 0.010 |
Why?
|
| ROC Curve | 1 | 2004 | 3575 | 0.010 |
Why?
|
| Macromolecular Substances | 2 | 1992 | 1433 | 0.010 |
Why?
|
| Actomyosin | 2 | 1976 | 109 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 3593 | 0.010 |
Why?
|
| Chemokines | 1 | 2000 | 954 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8833 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 1998 | 712 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1998 | 755 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6224 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1997 | 273 | 0.010 |
Why?
|
| Anilino Naphthalenesulfonates | 1 | 1975 | 16 | 0.010 |
Why?
|
| Myosin Subfragments | 1 | 1975 | 20 | 0.010 |
Why?
|
| Swimming | 2 | 1976 | 208 | 0.010 |
Why?
|
| Platelet Count | 1 | 1998 | 780 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1983 | 2913 | 0.010 |
Why?
|
| Arthritis | 2 | 1971 | 680 | 0.010 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 1997 | 352 | 0.010 |
Why?
|
| Agammaglobulinemia | 1 | 1997 | 171 | 0.010 |
Why?
|
| Aerosols | 1 | 1998 | 635 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 5672 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1483 | 0.010 |
Why?
|
| Basophils | 1 | 1977 | 407 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1975 | 306 | 0.010 |
Why?
|
| Models, Animal | 1 | 2001 | 2109 | 0.010 |
Why?
|
| India | 1 | 2001 | 2286 | 0.010 |
Why?
|
| Hylobates | 1 | 1994 | 13 | 0.010 |
Why?
|
| Uridine | 1 | 1975 | 140 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 21337 | 0.010 |
Why?
|
| Caspase 3 | 1 | 1997 | 731 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1975 | 229 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2004 | 2135 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3777 | 0.010 |
Why?
|
| Tritium | 1 | 1975 | 706 | 0.010 |
Why?
|
| Genomic Library | 1 | 1994 | 189 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 5766 | 0.010 |
Why?
|
| Chemical Precipitation | 2 | 1984 | 175 | 0.010 |
Why?
|
| Linear Models | 1 | 2004 | 5866 | 0.010 |
Why?
|
| Protein Deficiency | 1 | 1974 | 59 | 0.010 |
Why?
|
| Disulfides | 1 | 1996 | 464 | 0.010 |
Why?
|
| Breast | 1 | 1983 | 1963 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17878 | 0.010 |
Why?
|
| Leukemia | 3 | 1985 | 1520 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1997 | 831 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1994 | 851 | 0.010 |
Why?
|
| Radiography | 2 | 1997 | 6961 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2000 | 2567 | 0.010 |
Why?
|
| Ethylene Glycols | 1 | 1975 | 190 | 0.010 |
Why?
|
| Chondrocytes | 1 | 1999 | 792 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 2481 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1998 | 7583 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1998 | 2112 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 685 | 0.010 |
Why?
|
| Eosinophilia | 1 | 1998 | 559 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 1989 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8516 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 1975 | 532 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2002 | 3392 | 0.010 |
Why?
|
| Macaca | 1 | 1974 | 410 | 0.010 |
Why?
|
| Cartilage | 1 | 1996 | 806 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1993 | 141 | 0.010 |
Why?
|
| Urea | 1 | 1975 | 443 | 0.010 |
Why?
|
| Physical Conditioning, Animal | 1 | 1976 | 365 | 0.010 |
Why?
|
| Body Fluids | 1 | 1974 | 320 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1995 | 341 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1986 | 3232 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1974 | 562 | 0.010 |
Why?
|
| Pharynx | 2 | 1985 | 432 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1998 | 1348 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1998 | 2509 | 0.010 |
Why?
|
| Cross Infection | 1 | 2001 | 1422 | 0.010 |
Why?
|
| Blastocyst | 1 | 1994 | 432 | 0.010 |
Why?
|
| Organ Size | 2 | 1976 | 2252 | 0.010 |
Why?
|
| Albumins | 1 | 1974 | 575 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1991 | 222 | 0.010 |
Why?
|
| Urologic Neoplasms | 1 | 1995 | 314 | 0.010 |
Why?
|
| Angiography | 1 | 1997 | 1596 | 0.010 |
Why?
|
| Hepatitis B Antigens | 2 | 1983 | 38 | 0.010 |
Why?
|
| Heterozygote | 1 | 1998 | 2780 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4172 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1986 | 3222 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 1997 | 1096 | 0.010 |
Why?
|
| Pulmonary Valve | 1 | 1995 | 411 | 0.010 |
Why?
|
| DNA Replication | 1 | 1998 | 1414 | 0.010 |
Why?
|
| Adenocarcinoma | 4 | 1984 | 6340 | 0.010 |
Why?
|
| Coloboma | 1 | 1971 | 59 | 0.010 |
Why?
|
| Calcium | 2 | 1975 | 5717 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2001 | 1580 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1986 | 4020 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1996 | 1755 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1995 | 1092 | 0.010 |
Why?
|
| Lung Neoplasms | 3 | 1988 | 13382 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1986 | 5776 | 0.010 |
Why?
|
| Spinal Nerve Roots | 1 | 1970 | 121 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1997 | 2358 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1975 | 2495 | 0.010 |
Why?
|
| Weight Loss | 1 | 2001 | 2682 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1994 | 1519 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1972 | 590 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 1995 | 1336 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 3683 | 0.010 |
Why?
|
| Blood Platelets | 2 | 1994 | 2478 | 0.010 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 1995 | 628 | 0.010 |
Why?
|
| Magnesium | 1 | 1972 | 804 | 0.010 |
Why?
|
| H-Y Antigen | 1 | 1988 | 42 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 4524 | 0.010 |
Why?
|
| Rectum | 1 | 1993 | 891 | 0.000 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1998 | 1467 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 8542 | 0.000 |
Why?
|
| Brain | 2 | 1986 | 27101 | 0.000 |
Why?
|
| Demyelinating Diseases | 1 | 1970 | 352 | 0.000 |
Why?
|
| Jejunum | 1 | 1990 | 472 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1998 | 4910 | 0.000 |
Why?
|
| Ganglia, Spinal | 1 | 1970 | 525 | 0.000 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1996 | 1158 | 0.000 |
Why?
|
| Ileum | 1 | 1990 | 557 | 0.000 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1993 | 1492 | 0.000 |
Why?
|
| Hospital Mortality | 1 | 2001 | 5293 | 0.000 |
Why?
|
| Centrifugation | 1 | 1987 | 122 | 0.000 |
Why?
|
| Mesoderm | 1 | 1990 | 674 | 0.000 |
Why?
|
| Autopsy | 1 | 1970 | 1008 | 0.000 |
Why?
|
| Peroxidases | 1 | 1987 | 134 | 0.000 |
Why?
|
| DNA | 3 | 1985 | 7196 | 0.000 |
Why?
|
| Melanocytes | 1 | 1990 | 509 | 0.000 |
Why?
|
| Prednisone | 1 | 1991 | 1562 | 0.000 |
Why?
|
| Atrophy | 1 | 1991 | 1631 | 0.000 |
Why?
|
| Nerve Degeneration | 1 | 1970 | 747 | 0.000 |
Why?
|
| Embryonic and Fetal Development | 1 | 1987 | 420 | 0.000 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1986 | 360 | 0.000 |
Why?
|
| Monokines | 1 | 1985 | 71 | 0.000 |
Why?
|
| Prostaglandins E | 1 | 1985 | 166 | 0.000 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2001 | 3621 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1985 | 76 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1997 | 2533 | 0.000 |
Why?
|
| Cycloheximide | 1 | 1985 | 343 | 0.000 |
Why?
|
| Microbial Collagenase | 1 | 1985 | 112 | 0.000 |
Why?
|
| Scattering, Radiation | 1 | 1987 | 490 | 0.000 |
Why?
|
| Ear | 1 | 1985 | 172 | 0.000 |
Why?
|
| Esophageal Neoplasms | 1 | 1995 | 1653 | 0.000 |
Why?
|
| Microtubules | 1 | 1990 | 1073 | 0.000 |
Why?
|
| Mitogens | 1 | 1984 | 229 | 0.000 |
Why?
|
| Glomerular Mesangium | 1 | 1984 | 98 | 0.000 |
Why?
|
| Necrosis | 1 | 1988 | 1610 | 0.000 |
Why?
|
| Desmosomes | 1 | 1984 | 72 | 0.000 |
Why?
|
| Lymphocytes, Null | 1 | 1983 | 13 | 0.000 |
Why?
|
| Binding Sites, Antibody | 1 | 1984 | 337 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2001 | 7389 | 0.000 |
Why?
|
| Herpesviridae Infections | 1 | 1985 | 269 | 0.000 |
Why?
|
| Hybridomas | 1 | 1984 | 442 | 0.000 |
Why?
|
| Histocompatibility Testing | 1 | 1985 | 712 | 0.000 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 1982 | 10 | 0.000 |
Why?
|
| Lymphography | 1 | 1984 | 188 | 0.000 |
Why?
|
| Peanut Agglutinin | 1 | 1982 | 19 | 0.000 |
Why?
|
| Cytomegalovirus | 1 | 1987 | 749 | 0.000 |
Why?
|
| Cell Membrane | 2 | 1983 | 3680 | 0.000 |
Why?
|
| Blood Sedimentation | 1 | 1983 | 235 | 0.000 |
Why?
|
| Arteries | 1 | 1987 | 1122 | 0.000 |
Why?
|
| Dinoprostone | 1 | 1985 | 597 | 0.000 |
Why?
|
| Macaca fascicularis | 1 | 1984 | 901 | 0.000 |
Why?
|
| Meninges | 1 | 1984 | 197 | 0.000 |
Why?
|
| Hepatitis B Antibodies | 1 | 1983 | 155 | 0.000 |
Why?
|
| 3,3'-Diaminobenzidine | 1 | 1981 | 5 | 0.000 |
Why?
|
| Tumor Virus Infections | 1 | 1985 | 438 | 0.000 |
Why?
|
| Infectious Mononucleosis | 1 | 1982 | 133 | 0.000 |
Why?
|
| Antibodies, Antinuclear | 1 | 1983 | 342 | 0.000 |
Why?
|
| Culture Media | 1 | 1984 | 895 | 0.000 |
Why?
|
| Factor VIII | 1 | 1984 | 348 | 0.000 |
Why?
|
| Skin Manifestations | 1 | 1981 | 17 | 0.000 |
Why?
|
| Fibronectins | 1 | 1985 | 723 | 0.000 |
Why?
|
| Nasopharynx | 1 | 1984 | 400 | 0.000 |
Why?
|
| Cattle | 2 | 1977 | 3841 | 0.000 |
Why?
|
| Umbilical Cord | 1 | 1983 | 177 | 0.000 |
Why?
|
| Fibrin | 1 | 1984 | 507 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1978 | 4250 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2004 | 41457 | 0.000 |
Why?
|
| Sunlight | 1 | 1983 | 337 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1984 | 1031 | 0.000 |
Why?
|
| Hybrid Cells | 1 | 1981 | 422 | 0.000 |
Why?
|
| Capillaries | 1 | 1984 | 756 | 0.000 |
Why?
|
| Metabolic Clearance Rate | 1 | 1981 | 361 | 0.000 |
Why?
|
| Light | 1 | 1987 | 1352 | 0.000 |
Why?
|
| Fibrinogen | 1 | 1984 | 887 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1984 | 1972 | 0.000 |
Why?
|
| Orbit | 1 | 1984 | 457 | 0.000 |
Why?
|
| Congresses as Topic | 1 | 1985 | 802 | 0.000 |
Why?
|
| Computers | 1 | 1983 | 591 | 0.000 |
Why?
|
| Graft Survival | 1 | 1991 | 3820 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 12142 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1984 | 1964 | 0.000 |
Why?
|
| Asthma | 1 | 1998 | 6233 | 0.000 |
Why?
|
| Cytoskeleton | 1 | 1984 | 1170 | 0.000 |
Why?
|
| Pan troglodytes | 1 | 1979 | 223 | 0.000 |
Why?
|
| Head | 1 | 1984 | 922 | 0.000 |
Why?
|
| Dinitrobenzenes | 1 | 1977 | 37 | 0.000 |
Why?
|
| Freund's Adjuvant | 1 | 1977 | 145 | 0.000 |
Why?
|
| Neuroglia | 1 | 1983 | 955 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1995 | 5367 | 0.000 |
Why?
|
| Hemagglutination Tests | 1 | 1977 | 76 | 0.000 |
Why?
|
| Complement C4 | 1 | 1978 | 216 | 0.000 |
Why?
|
| Isoantibodies | 1 | 1981 | 671 | 0.000 |
Why?
|
| Immune Adherence Reaction | 1 | 1976 | 29 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1984 | 1333 | 0.000 |
Why?
|
| Research | 1 | 1985 | 1977 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2000 | 20556 | 0.000 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1982 | 491 | 0.000 |
Why?
|
| Tissue Donors | 1 | 1986 | 2331 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1981 | 1226 | 0.000 |
Why?
|
| Lung | 1 | 1974 | 9998 | 0.000 |
Why?
|
| Swine | 1 | 1985 | 5907 | 0.000 |
Why?
|
| Blood Protein Disorders | 1 | 1974 | 8 | 0.000 |
Why?
|
| Sodium Isotopes | 1 | 1974 | 11 | 0.000 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 1974 | 37 | 0.000 |
Why?
|
| Serum Globulins | 1 | 1974 | 23 | 0.000 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1974 | 71 | 0.000 |
Why?
|
| Plasma Volume | 1 | 1974 | 31 | 0.000 |
Why?
|
| Skin Tests | 1 | 1977 | 637 | 0.000 |
Why?
|
| Alpha-Globulins | 1 | 1974 | 26 | 0.000 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 1974 | 56 | 0.000 |
Why?
|
| Body Weight | 2 | 1976 | 4614 | 0.000 |
Why?
|
| Caseins | 1 | 1974 | 104 | 0.000 |
Why?
|
| Injections | 1 | 1977 | 832 | 0.000 |
Why?
|
| Gestational Age | 1 | 1983 | 3577 | 0.000 |
Why?
|
| Haplorhini | 1 | 1974 | 525 | 0.000 |
Why?
|
| Endometriosis | 1 | 1982 | 857 | 0.000 |
Why?
|
| Protein-Energy Malnutrition | 1 | 1974 | 189 | 0.000 |
Why?
|
| Lysine | 1 | 1977 | 993 | 0.000 |
Why?
|
| Radioisotopes | 1 | 1974 | 499 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1974 | 586 | 0.000 |
Why?
|
| Models, Biological | 1 | 1987 | 9461 | 0.000 |
Why?
|
| Edema | 1 | 1974 | 765 | 0.000 |
Why?
|
| Mitochondria | 1 | 1983 | 3619 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1976 | 2894 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1976 | 2410 | 0.000 |
Why?
|
| United States | 1 | 1985 | 72272 | 0.000 |
Why?
|